CD44 and neoplasm: Gene expression profiling of CD44+/α2β1hi/CD133+ primary cancer cells reveals a significant over-representation of the JAK-STAT signaling pathway, indicating aberrant alterations of this pathway in CSCs could accelerate the tumor load (Kroon et al., 2013).